Assignee
ENTERPRISE THERAPEUTICS LTD
GB·6 granted patents·1 pending application·3 citations·filing 2017–2025
Top patents by PatentIndex Score
7 records- 0185US12037336B2Compounds with activity as inhibitors of the epithelial sodium channel (ENaC)ENTERPRISE THERAPEUTICS LTD·Filed 2019·Granted Jul 16, 2024·3 cites·30 claims
- 0277US12371436B2Substituted benzodiazoliums as ENaC inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2023·Granted Jul 29, 2025·0 cites·24 claims
- 0376US2025304590A1Benzodiazolium compounds as enac inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 0466US11739094B2Substituted benzodiazoliums as ENaC inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2020·Granted Aug 29, 2023·0 cites·26 claims
- 0562US10941149B2Substituted benzodiazoliums as ENaC inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2017·Granted Mar 9, 2021·0 cites·21 claims
- 0641US11370778B2Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseasesENTERPRISE THERAPEUTICS LTD·Filed 2018·Granted Jun 28, 2022·0 cites·10 claims
- 0735US10759785B2CompoundsENTERPRISE THERAPEUTICS LTD·Filed 2017·Granted Sep 1, 2020·0 cites·32 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →